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Systemic lupus erythematosus (SLE) is a multiphenotypic autoimmune disease. The hallmark of
SLE is the production of anti-double-stranded DNA autoantibodies and the deposition of immune
complexes in target tissues such as the kidney, skin, and brain. Additional phenotypic traits are the
presence of arthritis, anemia, central nervous system involvement, and a variety of autoantibodies.
Females of childbearing age are particularly at risk. Recent genetic analysis of murine SLE shows
that susceptibility is under complex polygenic control. It is also apparent that environmental factors
contribute to the induction and exacerbation of SLE. We describe here the genotypic and
phenotypic characterization of a group of recombinant inbred strains of SLE-prone mice that were
derived from NZB and NZW progenitors, the parental strains of the classic female F, hybrid lupus
model. Recombination and reassortment of these ancestral genomes resulted in the NZM (New
Zealand mixed) strains with strain-specific patterns of renal disease penetrance and other
autoimmune traits such as Coombs positive anemia and neurologic deficits. Multiple susceptibility
loci of the ancestral strains demonstrate that SLE is inherited as a threshold trait. Because some of
these loci co-localize with the susceptibility loci of the insulin-dependent diabetes of nonobese
diabetic strain, it is apparent that there are disease-specific as well as autoimmunity-promoting
genes. It is proposed that the NZM strains, particularly those with reduced disease penetrance or
partial genotypes, provide an improved genetic model for assessment of the effects of
environmental agents on SLE and autoimmunity. Key words: autoantibodies, autoimmune disease,
effects of lead, genetic susceptibility, nephritis, New Zealand mixed mouse strains, NZB x NZW F,
hybrids, systemic lupus erythematosus. - Environ Health Perspect 107(suppl 5):713-721 (1999).
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The Human SLE Syndrome
Systemic lupus erythematosus (SLE) was first
considered a multiphenotypic disease syn-
drome by Moritz Kaposi ofVienna in 1872
(1). At the beginning ofthis century SLE was
already believed to be, at least in part, an
immune disorder on the basis ofobservations
offalse-positive syphilis serology in some
patients. SLE is the prorotypic autoimmune
disease, characterized by a large variety of
autoantibodies and a wide range ofclinical
manifestations and diverse organ involvement.
Once thought ofas a rare and invariably fatal
disease, improved diagnosis shows that 1:1000
women may be at risk to develop certain SLE
symptoms during their lifetime (2). SLE is
predominantly a disease ofw*nen ofchilbear-
ing age. It is estimated that in the United
States alone 400,000 to 1,000,000 suffer from
various forms ofSLE. Clinical manifestations
range from transient skin lesions or polyarthri-
tis to renal failure (3,4). Thiswide spectrum of
clinical pictures, and thus phenotypes, presents
difficulties in early diagnosis and treatment
and harnessing modern genetic analysis to
search for susceptibility loci and candidate
genes. Genome mapping depends on high
penetrance ofan unequivocal phenotype, i.e.,
the full expression in most individuals with the
same genotype. This is aproblem with the var-
ied clinical features ofSLE; furthermore, SLE
may not be asingle disease entity.
It was recognized early that SLE is a great
mimic of other diseases such as syphilis,
rheumatoid arthritis, hemolytic anemia, and
tuberculosis. Additionally, it was proposed
that there are genetic as well as environmental
components that contribute to this disease
(1,5). Exposure to ultraviolet (UV) radiation,
infection, diet, therapeutic drugs, physical
and mental stress, and hormonal status (preg-
nancy) can have profound effects on the
immune system and thus may contribute to
the pathogenesis of SLE (3-5). Family and
ethnic studies and investigations ofidentical
twins strongly suggest a genetic basis for this
syndrome as well as for the influence of the
environment on genetic susceptibility.
Because ofthe wide range ofthe SLE pheno-
type penetrance, it has been impossible to
resolve whether the environmental influences
on this disease initiate pathogenesis or
enhance the penetrance ofa low-grade, previ-
ouslyunrecognized phenotype.
The pathogenesis and etiology ofSLE are
only partially understood, but the hallmark is
an inappropriate immune response to several
autoantigens, particularly native DNA, chro-
matin, nucleoproteins, nucleosomes, histones,
phospholipids, myeloperoxidase, thyroglobu-
lin, and many other subcellular organelles (6).
The autoimmune response in SLE does not
appear to be an indiscriminate polyclonal acti-
vation of silent clones but several specific
antigen-driven responses, each under separate
genetic control. This implies that environ-
mental effects may also act in a specific fash-
ion. It is noteworthy that in SLE and diabetes
mouse models, evidence is accumulating that
each ofthese autoimmune humoral responses
is influenced or directed by separate and
diverse non-major histocompatability complex
(MHC) loci (discussed later). These autoim-
mune responses per se may not be pathogenic.
The formation ofDNA-anti-DNA autoanti-
body complexes in the circulation or in situ,
the generation of organ- or tissue-specific
cytotoxic T cells, and the generation of
inflammatory cascades and the release of
cytokines combine to cause severe chronic or
acute illness. These pathogenic immune reac-
tivities are modulated by neurologic and
endocrine functions. Thus, SLE is the result
of complex abnormalities of the neuro-
endocrine-immune networks.
Environmental insults on genetically
susceptible backgrounds are rational candidates
for the induction, recurrence, or exacerbation
ofSLE and other autoimmune diseases. Flare-
ups ofSLE are triggered in certain patients in
remission as a result ofinfection or exposure to
UV. However, other factors that modulate
immune responses such as diet and stresses ofa
physical, mental, or hormonal, nature should
also be considered (5). This is ample evidence
that environmental factors play an important
part in the pathogenesis ofSLE (5); moreover,
they may act as direct modulators ofa specific
immunologic function or affect the immune
system in a more complex interaction within
circuits ofthe neuroendocrine-immune net-
work. Such factors could act as substitutes for
epistatic genes that may potentiate, unmask, or
suppress a potential susceptibility gene or
immunoregulatorygene. Environmental factors
maytherefore act on certainsusceptibility genes
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such as interleukins to modulate the autoim-
mune responses (see "Effects ofEnvironment
onMurineSLE").
We propose (using a new mouse model of
SLE) that an environmental influence on SLE
may not be observable in individuals with the
full complement ofSLE genes, but that indi-
viduals with a number ofsusceptibility loci
below a certain threshold level will respond to
such an insult. Thus, an effect may be more
readily observed in a moderately lupus-prone
strain rather than in strains with already
extremely high disease penetrance. This is
apparent in some patients with transient SLE
symptoms when they have an adverse reac-
tion to a drug such as procainamide (7).
Thus, it may be a cumulative insult on the
immune system that triggers SLE in individu-
als with a partial genotype. This may also
account for the unusual discordance ofSLE
in some sets ofidentical twins in that the par-
tial genotype results in environmentally
dependent phenotypic expression, whereas
the full genotype alone is sufficient fordisease
in both identical individuals (8).
Geneticanalyses ofthe murine SLEmodels
provide support for the emerging concept
that SLE susceptibility involves a complex
interaction between SLE disease-specific as
well as pleiotropic autoimmune genes. Such
complexities make the genetic analysis ofhet-
erozygous families and ethnic groups difficult
until loci and candidate genes are mapped in
an appropriate mouse model such as the
female NZB x NZWF1 (BWF1) (9). The
genetic and phenotypic diversity ofthe NZM
(New Zealand mixed) recombinant inbred
mouse strains (10,11) and the congenic
strains derived from them (12-16) resemble
human patients more closely. They offer the
advantage ofproviding numerous identical
replicates with a defined susceptibility geno-
type and phenotype. Particularly informative
may be the inbred strains with partial pheno-
types and lowpenetrance.
This present artide describes the origin of
the SLE-prone NZM recombinant strains
and their unique phenotypic and genotypic
characteristics. The NZM recombinant
strains greatly extend the usefulness of the
original classical BWF1. We also review the
effect oflead (Pb) on the immune system and
the potential effects ofthis heavy metal on
SLE induction and exacerbation in genetic
variants ofSLE-prone mice.
The Murine Models ofSLE
Spontaneous SLE models [reviewed in
Theofilopoulos and Dixon (17)] in F1
hybrids and inbred strains (BWF1, NZB x
SWRF1, MRLIIprllpr/Mp, BXSB/Mp) have
offered an appropriate starting point to
investigate the effects of environmental
agents on genetic susceptibility and autoim-
mune disease progression. However, such
studies are hampered by some inherent
genetic and phenotypic problems: a) these
lupus models involve accelerating genes such
as lymphoproliferation (Ipr) ofMRL mice or
the male autoimmune accelerator (Yaa) of
the BXSB strain; and b) the SLE mice are
already at the extremehigh end ofsusceptibil-
ity and disease penetrance, making it difficult
to observe further significant environmental
influences with them. Conversely, normal
inbred strains lacking SLE or other autoim-
mune loci altogether may not be advanta-
geous for assessment of the effect of an
adverse environmental agent on autoimmune
disease induction or progression.
Origin oftheGenetic NZM
Model ofSLE
Sets ofrecombinant inbred strains as defined
by Bailey (18) are an indispensable tool of
genetics and permit an analysis ofpolygenic
traits and diseases that is not possible in het-
erogeneous backcross or F2 progeny. However,
breeding ofrecombinants from lupus progeni-
tors by the standard method has been difficult
because maintainingthe large numbers ofmice
required to obtain at least one line/strain with
the full phenotype is an overwhelming enter-
prise. Even when serendipity and an observant
mind played acritical role, thediscovery, selec-
tion, and propagation ofthe NZM recombi-
nant inbred strains became a costly and
labor-intensive undertaking that involved the
propagation ofmore than 100,000 mice. More
than 10,000 kidneys were examined, and hun-
dreds of mice were phenotyped for disease
course and anti-DNA and anti-red blood cell
autoantibodies. Genotyping for polymorphic
markers was done onseveralhundred mice.
Closely related SLE-prone, H2 identical
inbred recombinant strains with a wide range
of autoimmune phenotypic traits were not
available until the derivation ofthe NZM
strains (10). The NZM strains were bred from
NZB/BlUmc and NZW/OuUmc progenitors
in an unconventional manner, i.e., not directly
from pairs ofF2 progeny without selection.
While crossingNZB femaleswith NZWmales
to produce F1 hybrid females, an unintentional
cross occurred in 1980 amongF1 hybrids or an
F1 hybrid female with its NZWfather, the lat-
terbeing more likely. Recombination and reas-
sortment ofthe ancestral genomes resulted in a
litter ofmixed coat colors. Mice with a grey
coat color and red eyes [an example ofepistasis
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Figure 1. Percent cumulative glomerulonephritis in NZM
strains. The differences in the patterns of onset and
penetrance of renal disease vary among the strains.
Note that NZM 2410 female and male mice show a
more rapid time course than BWF1 females. Other
strains resemble BWF, or partial phenotypes; NZM 64 is
the most normal strain.
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ofthe pink-eyed dilution (p) gene on the
black (B) gene] were selected further for this
trait by pen-breeding and color selection
(1980-1981). Inbreeding was begun by A.
Gabrielsen at the Wadsworth Center (New
York State Department ofHealth, Albany,
NY) in late 1981 (10) when it became appar-
ent that some ofthe noninbred grey descen-
dents ofNZB/NZW ancestry succumbed to
early renal failure. Thus, the NZM strains are
the descendents ofa pair ofnon-inbred litter-
mates from agrey nephritic mother. The selec-
tion oflines was based on the presence and
patterns ofrenal disease and other criteria
deemed important by Gabrielsen (10), such as
the disappearance ofthe BWF1 hybrid gender
bias ofnephritis in one line (NZM 2410) or
lack ofor late onset ofrenal disease in other
Figure 2. Clinical features of systemic lupus erythemato-
sus (SLE) in strain NZM 2410. Overt renal failure results
in edema (left mouse), proteinuria, and elevated blood
urea nitrogen.
lines (NZM 64 and NZM 2758). A large
number oflines was started; some lines were
split atabout Flo to retain aduplicate orparal-
lel back-up line. About 28 lines attained strain
status (F20) and survived until 1995 (F35-F40).
At that time it became necessary to focus fur-
ther propagation on six strains with different
penetrance (NZM 2410, 2328, 88, 391, 2758,
and64).
Multiple NZM Phenotypes
To date, diverse phenotypic traits have been
observed in all or certain NZM strains as
delineated herein. Differences in nephritis,
neurologic deficit, Coombs positive anemia,
splenomegaly, CD5+ B cells, autoantibodies
to single-stranded DNA (ssDNA), double-
stranded DNA (dsDNA), chromatin, IgG,
histone, thyroglobulin, and myeloperoxidase
exist within the NZM strains. Furthermore,
the penetrance, degree, and onset ofsome of
these traits are important variables among the
strains, as is gender.
NephritisPhenotypes
The renal disease phenotype ofthe NZM
strains varies by time course and penetrance
(10). As shown in Figure 1, several strain-
specific patterns have emerged: a) rapid
onset ofsevere glomerulonephritis is present
in males and females ofstrain NZM 2410;
b) early onset in females, and delayed onset
in males are seen in strain NZM 2328; c)
some strains resemble the BWFI or interme-
diate patterns with early onset in females and
late onset in males (NZM 88 and 2754); and
d) intermediate incidence or absence of
nephritis were observed NZM 2758 (not
shown) and 64.
The highly penetrant expression ofnephri-
tis in NZM 2410 males and females is more
rapid than inBWFI females; maleBWFI mice
(data notshown) become nephritic after 12-18
months ofage. Nephritic NZM mice develop
proteinuria, azotemia, and edema (Figure 2).
Immunecomplexdeposits in theskin (19) and
hypertension phenotypes have not been deter-
mined (20). Glomerular lesions progress from
infiltration by neutrophils to accumulations of
mononuclear cells with concomitant mesangial
matrix expansion and cellular proliferation.
The mice succumb with florid crescentic
glomerulonephritis or diffuse end-stage
glomerulosclerosis (Figure 3A-C). Tubulo-
interstitial abnormalities showdiversehistologic
features such as hyaline casts, tubular atrophy
and drlitation, and interstitial mononudear cell
infiltrates. Arteritis or accumulations of
mononudearcells aroundsmall arteries is often
seen. There mayactually be several histopatho-
logic renal disease phenotypes that have not
been systematically investigated; however,
Morel et al. (11) mapped the acute form of
nephritis (renal failure before 44 weeks ofage).
The phenotype ofdelayed-onset type nephritis
could not mapped. Someaging mice are found
dead with relatively normal renal histology but
massive diffuse glomerular hyaline thrombus
formation; whether this is a subphenotype of
murine SLE is not known. Immunofluorescent
patterns of immune complex deposits in
peripheral capillary loops and mesangial areas
ofglomeruli (IgG, IgM, and C3) are quite
similarto thoseseen inBWF1 femalemice.
Figure 3. Examples of renal histopathology in NZM mice. Kidney sections from a male mouse 179 days of age(A) and from a female mouse 221 days of age (B), both NZM 2410,
have typical diffuse lupus glomerulonephritis showing sclerosis, "wire loops," hyaline thrombi, inflammatory infiltrates, and karyorhexis. Both mice were edematous.
(C) Representative normal glomerulus of a male mouse of strain NZM 64, 180 days of age. Magnification 380x. Periodic acid-Schiff-Alcian Blue stain. Reproduced from Rudofsky
et al. (10)with permission of the US-Canadian Academy ofPathology.
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NeurologicDeficits
Postural neurologic deficits were described in
BWF1 hybrids by Kier (21). The phenotype
is present in some oftheNZM strains (Figure
4A-D). This phenotype segregates indepen-
dently from nephritis (Figure 5) and is also
variably penetrant (Figure 6), suggesting that
this trait may also have a genetic threshold
mode ofinheritance (discussed later). Brain
capillaries contain immune-complex-like
deposits of IgG and IgM; however, an
immunopathologic mechanism for this pos-
tural abnormality has not been established.
Electron-dense deposits in brain capillaries
resembling immune complexes have been
described in BWF1 (22).
OtherSLEPhenotpes
Anti-dsDNA autoantibodies, the hallmark of
SLE, are present early in life in most NZM
mice, a notable exception being strains 64
and 2758. These strains have low titers late in
life, ifever (Table 1). Titers ofanti-dsDNA
do not consistently correlate with the
nephritic phenotype (11). The most compre-
hensive data on serologic testing for autoanti-
bodies of NZM 2410 have been recently
reported by Morel et al. (16). There was a
high incidence ofseveral autoantibodies: IgM
anti-ssDNA and IgG anti-dsDNA, IgM anti-
IgG, and antibodies to chromatin, histone,
nuclear proteins, nucleosomes, thyroglobulin,
and myeloperoxidase. These findings are
remarkably similar to findings in patients
with SLE.
The main autoimmune phenotype ofthe
NZB mouse strain is Coombs positivity
(antierythrocyte autoantibodies). Most mice
succumb to anemia. Fulminating crescentic
glomerulonephritis with edema, as seen in
BWF, females, was a rare phenotype in the
NZB/B1Umc strain. Aging male and female
NZB and NZW mice (>12-18 months of
age) develop varying degrees of focal or
diffuse glomerulosclerosis. Direct Coombs
tests show that this phenotype is expressed in
some NZM strains with variable penetrance
and at low titers (Table 1). Nevertheless, in
strain NZM 2410 this trait appears to exceed
the prevalence in BWFI hybrids (30% vs
5%). Liver and spleen histology ofaffected
miceshowan increase inerythropoiesis.
Recently, Mohan et al. (23) reported the
presence ofexpanded populations ofBlacells
(CD5+ B lymphocytes) in strain NZM 2410.
However, this NZB trait of CD5+ hyper-
diploid B cells has also been identified in
nonnephritic or low-penetrance strains NZM
64 and 2421 (24). The time oftheir appear-
ance and their quantity in spleen and peri-
toneal cavity were not assessed. Splenomegaly
that is attributable to lymphoproliferation
was seen in NZM mice.
Notably, the role of the complement
cascades has recently received little attention
in the murine SLE equation. In the BWFI
Figure 4. Postural responses of NZM mice at 6 months of age. (A) Strain NZM 2328: the normal posture reflex with
spreading of hind limbs and toes, raising of head. (B) Strain NZM 64: the partial phenotype with moderate hind limb
adduction and curling inward of toes, lack of head orientation. (C,D) Strain NZM 88 with the severe postural deficit
phenotypewithclasping offore and hind limbs.
Fgure 5. Differential segregation of nephritis and neuropathy. Assessment ofthe nephritic and neurologic conditions
of NZM strains. Note that each strain has a different combination of two segregating phenotypes. Scores of 0 to 4+
were assigned to the overall expression of abnormalities.
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Figure 6. Percent cumulative postural response deficit in
NZM strains. Abbreviations: F, female; M, male. Variations
in the penetrance and time course are apparent. (A) NZB
mice show high penetrance of pronounced impairment
compared to NZW and NZM 2410. (B) NZM 391 has an
intermnediate phenotype,whereas NZM 2328 appears to be
normal. (C) NZM 88 is comparable to NZB and the impair-
ment is severe. NZM 64 has an intermediate phenotype
withmoderate clinical features(asshown in Figure4B).
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model, Cl activity dedines to virtually unde-
tectable levels (25). Clq knockout mice
develop SLE symptoms (26). Furthermore,
Clq is near a strong susceptibility locus
(Nbal) (discussed below). It is ofinterest that
all NZM strains except the least nephritic
NZM 64 strain are C5 deficient, a NZB trait
on chromosome 2. Furthermore, all NZM
strains are C4 (C4-Slp) deficient, aNZWtrait
on chromosome 17 (10). C5 deficiency was
proposed as a possible susceptibility locus by
Lanier et al. (27). Complement component
deficiencies play an important role in human
SLE (3,4). As alreadynoted, some susceptibil-
ity loci in NZM 2410 are near complement
componentandreceptorgenes.
Genetic Characterization
ofthe NZM Strains
To deploy the NZM strains as an excellent
model oftheeffect ofenvironmental toxicants
on susceptibility to SLE and autoimmunity, a
briefreview oftheir genetic characterization is
necessary. The analysis ofNZ mice and other
SLE strains [reviewed in Vyse and Kotzin
(28)] uncovered a complex pattern ofthe
genetic controls ofSLE. As described earlier,
the NZM strains were derived from the NZB
and NZW strains that are the basis for the
original dassical murine model ofSLE in the
F, female hybrids (9). The NZM strains are
H2 identical (H-Z ofNZW), recombinant
inbred strains containing portions oftheir
ancestral genomes through reassortment and
recombination (Tables 2, 3) (10). It was pro-
posed many years ago that both strains con-
tribute one or two MHC-linked lupus genes
and that heterozygosity at H2 is an essential
component (29). Despite MHC homozygos-
ity(H2z), NZM 2410 hassevereearlynephri-
tis (Figures 1, 2, and3).
Conventional analysis ofpolymorphic
markers (Table 3) did not uncover any SLE
loci, but it provided important insights into
the diverse genetic makeup and integrity of
the strains. It is significant that the original
selection ofgrey mice, i.e., for the NZW
recessive pink-eyed dilution (p) on a recombi-
nantNZWINZB chromosome 7 (retention of
Table 1. lgG anti-dsDNA and anti-red blood cell auto-
antibody profiles in NZM strains.a
Anti-DNA Coombs
Strain (% positive) (% positive)
NZB 55 92
NZW 47 0
2410 88 33
2328 83 0
391 83 8
88 100 6
2758 10 5
64 22b 0
dsDNA, double-stranded DNA. 'Mice were tested between 6
pink-eyed-dilute, loss ofalbino), provided the
serendipitous basis for selection that resulted
in the discovery oftwo strong NZWSLE loci
more than 15 years later: Sk3 is linked closely
to p and Sle 5 is near the NZW centromere
(Tables 3-5) (11,16). Extensive genetic
studies were done to map SLE loci using
NZM 2410 with highly penetrant renal dis-
ease in both sexes. Wakeland and colleagues
(11-16,30) analyzed crosses ofNZM 2410
(NZM) and C57BL/ 6 (B6) mice: (NZM x
B6)F1 hybrids, (NZM x B6) x NZM back-
crosses, and (NZM x B6)F2 hybrids.
Furthermore, congenic B6 strains are being
constructed that contain one or more ofthe
mapped SLE loci or smaller intervals of a rele-
vant mapped genomic segment to more
closelyidentifycandidate genes and the effects
ofthese loci on the SLE composite pheno-
types. These congenic strains may greatly
enhance the usefulness ofthe NZM model for
assessing environmental effects on autoimmu-
nity. Conversely, these congenic and subcon-
genic strains will also provide an excellent tool
to examine therapeutic interventions. For
example, nephritis in NZM 2410 can be pre-
vented with anti-CD4OL monoclonal anti-
bodies. This prophylactic treatment could be
analyzed in detail in the congenic and subcon-
genicstrains ofNZM 2410 (31).
It is important to consider the genetic
contributions ofnormal strains used in the
analysis ofsuch crosses. For example, NZM
2410 x B6F, crosses develop anti-DNA anti-
bodies, albeit slowly (11). B6 also contributed
genomic segments to the lupus-prone MRL
and BXSB mice and may harbor some
autoimmune genes. To analyze this phenome-
non further, we made backcrosses ofNZM
2410 to the ancestral NZB and NZW strains
and F1 crosses with BALB/c ByJ and SM/J
(32). The preliminary results provide pre-
sumptive evidence for genetic complementa-
tion or epistasis. Unlike B6, BALB/c mice did
not provide a permissive genetic environment
for NZM genes to induce detectable titers of
anti-DNA antibodies or nephritis. However,
similar to B6, one BALB/c mouse had histo-
logic renal lesions after 477 days ofobserva-
tions; whether this was SLE nephritis could
Table2 NZM genotypes based on NZB and NZWconventional polymorphisms.a
Chromosome number
Strain 1 2 3 4 7 9 14 17
NZB B B B B B B B B
NZW W W W W W W W W
2410 B/W B B W/B W/B B B W
2328 W B B B W/B B B W
2758 W B B B W/B B W W
391 B/W B B W W/B B B W
88 B/W B B B W/B W W W
64 B/W W/B B B W/B W W W
Abbreviations: B, NZB;W, NZW.'1/WorW/B means recombination proximal/distal.
Table3. Polymorphic markerprofilesofthe NZM strains.
Strain
Chromosome Locusa NZB NZW 2410 2328 2758 391 88 64
1 Idhl(27) B W B W W B B B
Pep3(49) B W W W W W W W
2 Hc(C5(18)) B W B B B B B W
A(62) B W B B B B B B
3 Cdm(82) B W B B B B B B
4 b(35) B W W B B W B B
Ahdl(59) B W B B B W B B
Akp2(60) B W B B B B B B
Aial(72) B W B W? B B B W?
7 p(28) B W W W W W W W
c(42) B W B B B B B B
9 Modl(44) B W B B B B W W
14 EslO(27) B W B B W B W W
15 Ly6(20) B W W W W W W W
Gptl(28) B W W W W W W W
17 H2Ku(18.5) B W W W W W W W
H2AU(18.7) B W W W W W W W
H2S1(18.8) B W W W W W W W
Tnf.c(19.0) B W W W W W W W
H2Y(19.1) B W W W W W W W
Ce2(21 ) B W W W W W W W
B, NZB;W, NZW.¶ocusdesignation (approximate location incentimorgans IcM).
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not be determined. Both NZB and NZW
supported the expression ofsevere nephritis
with 70-75% penetrance, but the time
courses differed. The NZW x NZM 2410
cross provided homozygosity at the three
mapped SEloci (Table 4), but this resulted in
the delayed onset ofsevere nephritis (day 379
± 142). The rapid onset ofnephritis (day 218
± 111) in the NZM 2410 x NZB cross may
have been due to H2 heterozygosity (Sle4)
(11) or other accelerating, epistatic, or com-
plementing genes present in NZB. The pre-
sumably normal SM/J strain provided genes
to promote SLE in the F1 hybrids (40%).
Unexpectedly, one SM/J breeder female
mouse alsodiedwithsevere lupuslike nephritis,
suggesting that this strain may indeed contain
some SLE susceptibility loci. These findings
may complicate the use ofthe NZB x SM
Table4. Systemic lupus erythematosus loci in NZB and NZA
recombinant inbred strains NXSM/Ei for SLE
geneticanalysis (28,33).
These and other complex breeding and
mappingstrategieshaveuncoveredasubstantial
number ofSLE loci [reviewed in Vyse and
Kotzin (28)]. Some ofthese susceptibility loci
(named Sk, Lbw, Sbw, Nba) are summarized in
Table 4 along with their phenotype expres-
sions. Several other NZ recendy mapped non-
MHC loci contribute to the control of
autoantibody formation to DNA, nucleopro-
teins, myeloperoxidase, and thyroglobulin
(16). Previously, murine SLEinBWF1 hybrids
was thought to be controlled by one or two
dominant loci derived from the MHC region
ofeach parent (28). SLE-promoting effects of
H2heterozygosity (SI4) can be seen in several
strain combinations. However, a complex
interaction ofMHC loci and non-MHC loci
Chromosome Locus(cM)b Phenotype Strain origin
1 Sbwl (52) Splenomegaly B
1 Lbw7(60) Antichromatin B
1 Nba2(70) Antichromatin B
1 Slel (73) GN/antichromatin W
4 Sle2(44) GN/B-cell hyperactivity W
4 Sbw2(53) Splenomegaly B
4 Lbw2(53) GN/mortality B
4 Nbal(69) GN/mortality B
5 Lbw3(88) Mortality W
6 Lbw4(56) Mortality B
7 Sle5(2) Anti-dsDNA W
7 Lbw5(22) Mortality W
7 SIe3(27) GN W
7 Nba3(50) Antichromatin B
11 Lbw8(30) Antichromatin B
17 Lbwl(20) Antichromatin/GN/mortality H2Zlz
17 Sle4(20) GN H2'/z
18 Lbw6(49) GN/mortality W
Abbreviations: B, NZB; ds-DNA, double-stranded DNA; GN, glomerulonephritis; W, NZW. Susceptibility loci associated with auto-
immune entities (11,16,28). hLocus designation, approximate location incentimorgans (cM).
Table 5. Hypothetical distribution of mapped and proposed NZB/NZW systemic lupus erythematosus susceptibility
loci in NZM strains.
Systemic lupus Polymorphic Strains
Chromosome erythematosus locia markers 2410 2328 88 391 2758 64
1 Sbwl(52)B Pep3(49)W - - - - - -
Lbw7(60)B - - - - - -
Nba2(70) B
Sle1 (73)W + + + + + +
2 C50(18) B Hc°(18) B + + + + + -
4 SIe2(44)W b(35)W + - - +
Nba1(69) B Akp2(60) B + + + - + +
Lbw2(53) B + + + - + +
Sbw2(53) B + + + - + +
7 SIe3(27)W p(28)W + + + + + +
Lbw5(22)W + + + + + +
Sle5(2)W + + + + + +
Nba3(50)B c(42)W + + + + + +
17 SIe4(19)B/W H2(19)
Lbwl(19)B/W - - - - - -
C40(19)W H2S(19)W + + + + + +
Tnf-x(19)W H2(19)W + + + + + +
Abbreviations: +/-, presence or absence of locus; B, NZB; W, NZW. "Locus designation, approximate location in centimorgans (cM),
and strain origin.
on several chromosomes, the apparent involve-
ment ofcomplementation, and epistasis genes
make the genetic analysis ofSLE unexpectedly
difficult even in an inbred mouse system. At
present there are more than a dozen loci that
map with varying degrees ofstatistical confi-
dence to 15 ofthe 19 autosomal chromosomes
[reviewed in Vyse and Kotzin (28)]. This list is
expectedto growconsiderably.
Although NZM 2410 mice are being
phenotyped and mapped in ever greater detail
(11-16,30), the genetic makeup ofthe other
NZM strains remains tentative. Table 5 sum-
marizes a hypothetical view ofthe distribution
ofsome ofthe mapped and proposed loci
deduced from several nearby known polymor-
phisms such as coat color genes on chromo-
somes 2, 4, and 7 (agouti, brown, pink-eyed-
dilute, and albino, respectively). Skel ofNZW
on chromosome 1 appears to be present in all
NZM strains. The NZB loci may be absent.
Chromosome 2 is recombinant only in NZM
64 (C5+/nonagouti); this provides a possible
protective (C5-sufficient) locus (27). On chro-
mosome 4, the close linkage of SIe2with b
(brown) ofNZW shows that the two pink-
eyed-dilute/brown (tan) strains (2410 and
391) contain this locus; however, 2410 also
has most probably the additional NZB loci
Nbal, Lbw2, and Sbw2. Chromosome 7 is
recombinantand retainedp(pink-eyed-dilute)
and lost c (albino). This fortuitous mixing of
the NZB/NZW genome on chromosome 7
suggests that all these mapped loci (Table 5)
are present in all six strains, particularly SIe3
that is closely linked top. The all-important
MHC SLE loci are only partially, but uni-
formly, present in the NZM strains. All are
homozygous for the NZW H2complex (K",
Iu, SZ, D!), which implies that the direct or
epistaticeffects ofSIe4ILbwl (heterozygosity at
HZ) are absent in all strains. The mechanism
by which this heterozyotic element imparts its
influence on renal disease is unknown.
However, the possible predisposing loci, C4
(10) and tumor necrosis factor (TF)-at (34)
deficiencies, are present in all NZM strains.
Thus, this hypothetical as well as established
geneticdiversityofthestrains mayprovidefur-
ther important information. Table 5 suggests
thatgeneticdifferenceson chromosomes2 and
4 could be responsibleforthesubstantial pene-
trancedifferences amongthesixNZM strains.
There is now ample evidence that murine
lupus and manyofthe associated autoimmune
phenomena are under polygenic control and
that the penetrance, time course, and severity
ofdisease are influenced by a large number of
susceptibility loci. It is important to recognize
that some ofthese SLE loci colocalize with
autoimmune insulin-dependent diabetes (Id
loci of nonobese diabetic (NOD) mice
(28,35). These findings support the concept
that disease-specific loci as well as pleiotropic
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autoimmune loci must be considered. These
loci interact in various combinations to fit a
threshold liability model (Figure 7) (11). The
linkage studies lead to the conclusion that the
accumulation ofmultiple component pheno-
types results in the diverse forms ofthe SLE
syndrome. These traits may have to exceed
several thresholds for the disease to become
overtly manifest. There may also be epistatic
loci that suppress or alter the level ofexpres-
sion. It is significant that many ofthese SLE
susceptibility loci map in or near regions that
code for interleukins, interferons, tumor
necrosis factor, complement components,
and their receptors, i.e., candidate genes that
are intimately involved with immunoregula-
tion, inflammation, and the clearance or dis-
solution ofimmune complexes. Furthermore,
there must be genetic controls ofthe synthesis
ofautoantigens in a pathogenic configuration
or at an abnormal rate. Such loci have not
been identified.
We propose that some ofthe interactions
of susceptibility loci or epistatic genetic
effects may be affected or substituted by
environmental factors.
Effects ofthe Environment
on Murine SLE
The new NZM model represents a significant
advance in studying environmental influences
on SLE and autoimmunity in general. The
main features ofthis model are the high, par-
tial, and lowexpression ofseveral autoimmune
and disease phenotypes in MHC-identical
strains that also have inherited mixed propor-
tions ofsusceptibility (Table 5) and resistance
genes from the NZB and NZW progenitors
(hence, New Zealand mixed), making it
possible to add a novel genetic dimension for
assessing the effects ofthe environment on
autoimmunity. In addition, the generation of
congenic and subcongenic strains with the
z
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Figure7.Penetrance ofacuteglomerulonephritis as afunc-
tion of the number of Slealleles. GN, glomerulo-nephritis.
The frequency of nephritis (diamonds) demonstrates dis-
ease as a function of the number of susceptibility alleles.
Various combinations of the recessive NZW Sle loci gave
similar results. Note the potentiating effect of the fourth
locus (SIe4) of heterozygosity at H2. Vertical intervals indi-
cate 95% confidence intervals. Reproduced from Morel et
al.(11)with permission ofCell Press.
single or multiple SLE intervals ofNZM 2410
may permit the dissection ofenvironmental
effects on specific autoimmune loci or genes in
greaterdetail (30).
Operationally, these loci can be categorized
as controlling: a) loss oftolerance for specific
self-antigens; b) amplification or dysregulation
ofhumoral and cellular immune responses and
functions; c) availability of antigens for
immune complex formation; d) induction or
amplification of target tissue injury; and
e) interference with removal ofimmune com-
plexes. The genetic control for the production
and release ofaltered or immunogenic self-
antigens has not been addressed. All these can
be potentially manipulated directly or indi-
rectlybytheenvironment.
Use ofPb as a prototypic environmental
effector in a genetic model ofSLE is based on
the well-documented specific impacts that Pb
has on the immune system [reviewed in
McCabe and Lawrence (36), Lawrence
(37,383, and Lawrence and McCabe (39)] and
is provided as an example ofposited means by
which an environmental agent could interface
with genetics to affect autoimmune disease
incidence. On the basis ofprevious observa-
tions in BWF1 mice (Tables 6, 7) and the curi-
ousfactthatPb intoxication ofnormal micefor
more than 1 year does not cause renal lesion or
autoimmunity or mortality (40,41), it is sug-
gested that without particular and defined
genetic backgrounds, Pb does not induce the
SLEphenotype orautoimmunity ingeneral.
The effects ofPb on humoral and cellular
immunityofrnicehave beenwell characterized,
and Pb can be considered an experimental
paradigm for environmental influences on the
immune system. It is therefore possible that
alterations in immunoregulatory mech-anisms
Table 6. Lead effects on female and male BWF1 mice.a
Mortality
Pb dose(mM) Female Male
0 50% 34weeks 0% 60weeks
2 50% 40weeks 50% 40weeks
10 30% 44weeks 50% 58weeks
Pb, lead. 'Mice were started on 0, 2, or 10 mM Pb acetate in
theirdrinking water at 10weeks of age.
could initiate or exacerbate SLE in individuals
with a sufficient genetic predisposition, i.e.,
mice with subthreshold numbers ofSLE loci
(see above). Unlike other heavy metals (Hg,
Au, Cd), Pb does not induce toxic or autoim-
mune renal diseases in normal CBA/J mice
exposed for 16-24 months to 2-10 mM PbCl
in drinking water; there were no increases in
immune complex deposition in the glomeruli
(38). In one such exposure, parents were
treated prior to conception, with offspring
exposed throughout fetal, newborn, and adult
life (37,39). Pb was found to be nonnephrito-
genic in these mice. As discussed in a recent
review(36), BCFi micealsodisplaynosignsof
ill healthandactuallyhavealoweraccumulated
mortality than control mice. However, ifPb-
exposed mice are given any infectious agent,
their health, i.e., immunity, is compromised to
a greater extent than that ofcontrol mice
regardless ofstrain. In BALB/c or BCF1 mice
exposed to Pb in vivo, cytokine levels are modi-
fied (44). Interleukin (IL)-4 levels are elevated
and interferon (IFN)-ylevels are lowered. Ifit
can be demonstrated that an environmental
agent can influence SLE in an NZM strain, we
may be able to determine the degree ofalter-
ation ofpenetrance. These data would allow
evaluation ofwhether an environmental agent
can initiate autoimmune disease or exacerbate
the disease process (heighten the pathology or
cause itto occurearlier).
Unlike normal strains of mice, BWF1
lupus-prone mice showed an unusual
response and gender difference during long-
term exposure to Pb (Tables 6, 7). When
mice were left untreated, mortality was as
predicted: 50% at 34 weeks for females, 0%
at 60 weeks for males; 2 mM Pb resulted in
loss ofmale resistance: 50% mortality by 60
weeks. As BWF1 females are at the peak
expression ofthe SLE phenotype, additionally
induced changes were more difficult to
observe. On the basis ofthese observations, it
follows that it is possible to effect temporal,
quantitative, and qualitative shifts in the
expression ofmurine SLE byexposure to Pb.
Several immunologic mechanisms are
affected by Pb administration that could
accelerate or modify SLE. Pb is known to
Table 7. Lead effects on mitogen-induced and mixed lymphocyte cultures and plaque-forming colony responses of
surviving male BWF1 mice.ab
Pb dose Blood Pb Responses
(mM) (pg/dL) ConA LPS MLC PFC
0 2 ± 0 2,389 8,896 2,026 80 ± 48
±3,912 ±2,820 ±966
2 39 ± 13 2,965 4,694 1,741 899±923
± 2,770 ±3,425 ±1,216
4 377±174 1,566 9,920 1,740 4±7
± 1,365 ±8,963 ±769
Abbreviations: ConA, concanavalin A; LPS, lipopolysaccharide; MLC, mixed lymphocyteculture; Pb, lead; PFC, plaque-forming colonies.
,Mice were exposed to Pb acetate in the drinking water for 50 weeks prior to the in vitroanalysis. hValues are based on cpm or PFC
per microculture.
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amplify humoral immune responses. It modi-
fies or reduces the number of available
macrophages, thus diminishing the efficient
removal of immune complexes, which are
known to accumulate in various tissues in
SLE-prone mice. It is possible that Pb could
alter the clearance of immune complexes by
the glomerular mesangial cells (related to
macrophages) of the kidney. It has also been
reported that Pb increases T-cell responses by
upregulating MHC class II expression and
that there can be a general enhancement of
both B- and T-cell functions (43,44).
Furthermore, Pb modifies cytokine patterns
throughout the body including the central
nervous system, a significant partner of the
immune and endocrine systems.
Pb modifies the cytokine networks (45) in
a fashion similar to that observed in SLE-prone
mice (46), that is, with elevated levels ofthe T
helper (Th)2-promoting cytokines and
depressed levels ofTh1-promoting cytokines.
In fact, IL-10 (cytokine synthesis inhibitory
factor) is produced by macrophages, B cells,
and Th2 cells, and is able to block IL-12 pro-
duction, which promotes development ofThl
cells. It is ofinterest, therefore, that SLE sus-
ceptibility loci Slel and Nba2on chromosome
1 are near IL-10 and a number ofcomplement
proteins and Fc receptor genes (28,35). In gen-
eral, cytokines play a central role in the patho-
genesis ofhuman and murine SLE (47-49).
These observations are supported by the fact
that some ofthe susceptibility loci are closely
linked to cytokine genes. Slel is near IL-10
(see above and S1e2 maps near IFN-ar and
IFN-3 on chromosome 4 (11). S/eS is virtually
identical with the locus for IL-11 on chromo-
some 7 (16). Furthermore, a new locus identi-
fied by Morel et al. (16) on chromosome 11 is
near a cluster of IL genes for IL-3, 4, 5, and
13. Some ofthese loci co-localize with suscep-
tibility intervals ofthe NOD mouse (28,35)
discussed above.
IL-6 positively correlates with active
disease (47,48), and IL-6 has been reported
to promote SLE in BWFI mice (49). One
environmental promoter of SLE is sunlight
(UV exposure), which exacerbates SLE (the
photosensitivity of SLE ) by enhancing IL-6
generation in SLE patients (50). The genera-
tion of abnormal amounts of interleukins
may contribute to the potentiation of the
pathogenic activity displayed by immune
complex deposits in the epidermal-dermal
junction ofsun-exposed skin.
Another well-documented Pb-affected
cytokine that enters the SLE equation is TNF-
a (34). Here again, murine lupus susceptibility
loci in NZM strains (Table 5) provide genetic
clues: the NZW TNF-a defect maps to H2
(chromosome 17) and Nbal maps near the
NZB Tnfr2 (chromosome 4). Some NZM
strains may contain these genes (Table 5).
Recent studies by Fujimura and colleagues
(51) in H2-congenic NZB and NZWF1
crosses demonstrate that the TNF-a and
MHC class II polymorphisms of NZW are
distinct susceptibility loci that modulate NZB
alleles directly or epistatically.
Because Pb and other environmental
toxicants may have profound effects on the up-
or downregulation of IL, IFN, and other
chemokines, vasoactive substances, adhesion
molecules, and too many others to elaborate
on, the role ofenvironmental agents must be
assessed in a set ofgenetically defined variants
oflupus-prone mice. As demonstrated herein,
the NZM strains resemble the human spec-
trum ofSLE by virtue oftheir varied pheno-
type and complex patterns ofinheritance.
Using genetically defined mice with identical
immune response loci (MHC class I and class
II genes) but with different degrees of SLE
penetrance should allow more definitive analy-
sis ofthe ability ofan environmental agent to
initiate or exacerbate an autoimmune disease.
Further, it may be possible to delineate the loci
most influenced by the environmental agent.
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